BPOM Probiotic Regulation: The Complete 2026 Guide for Foreign Investors and Exporters to Enter Indonesia

Indonesia’s supplement market is booming. For foreign brands, probiotics represent one of the most promising entry points.

But before a single capsule reaches an Indonesian shelf, it must navigate one of Southeast Asia’s most rigorous regulatory frameworks.

BPOM probiotic regulation in Indonesia has undergone a major overhaul in 2025. The new rules are stricter, more science-driven, and more consequential for anyone planning to register or sell probiotic supplements in the country.

Whether a company is an established exporter testing the waters or a new investor building a presence from the ground up, understanding these rules is not optional. It is the foundation of a viable Indonesian market strategy.

This guide unpacks everything that matters: the new regulation, its scientific demands, how foreign companies must legally structure their market entry, the role of halal certification, a realistic cost picture, and the mistakes that consistently derail foreign investors in this space.

Why Indonesia’s Probiotic Market Deserves Serious Attention

Indonesia is home to more than 280 million people, a rapidly growing middle class, and a consumer culture that is increasingly receptive to preventive health products.

The market for probiotic supplements in Indonesia’s main urban centers, such as Jakarta, Surabaya, and Bandung, has consistently shown strong growth, with double-digit increases, driven by products targeting digestive health and immunity. Health awareness accelerated sharply following the COVID-19 pandemic, and the positive momentum has not subsided.

What makes Indonesia particularly attractive for foreign supplement brands is the combination of scale, developing regulatory maturity, and a relatively underserved probiotic category compared to markets like South Korea, Japan, or Australia.

The regulatory tightening happening right now under PerBPOM 17/2025 is not a barrier. Handled correctly, it is a competitive moat. Brands that register compliantly early will be far better positioned than those that wait and rush later.

Key Market Facts

•   Indonesia is the fourth most populous country in the world.

•   Halal-certified supplement products have a significantly wider addressable market among the Muslim-majority population.

•   BPOM-registered supplements command stronger retailer and pharmacy confidence.

•   The growing e-commerce sector further lowers distribution barriers once a product has its distribution permit (izin edar).

PerBPOM 17/2025: The New BPOM Probiotic Regulation Framework

On 23 June 2025, Indonesia’s Head of BPOM, Taruna Ikrar, signed BPOM Regulation Number 17 of 2025.

The regulation is officially titled the Guidelines for Assessment of Health Supplement Products Containing Probiotics (PerBPOM 17/2025). It replaces the previous PerBPOM 17/2021 and represents a fundamental shift in how probiotic-based supplements are evaluated, classified, and permitted for distribution in Indonesia.

The core driver behind the new regulation is the recognition that probiotics are fundamentally different from standard supplements. Because they contain living microorganisms, they require a distinct scientific assessment framework that addresses strain identity, viability, safety, and efficacy.

The old 2021 guidelines were considered too general. The 2025 version introduces a comprehensive, structured system.

What PerBPOM 17/2025 Actually Requires

The regulation expands the scope of assessment across four interconnected areas:

1. Strain Identification and Classification: Every probiotic strain must be clearly identified using proper scientific nomenclature (genus, species, and strain). Manufacturers must demonstrate that the strains used are real, verified, and traceable.

2. Safety Assessment: Comprehensive safety data must be submitted covering the microbiological profile, antibiotic resistance potential, and any known adverse effects associated with the strain or strain combination.

3. Efficacy Evidence: Clinical trial data is required for new, unregistered strains and for products making advanced health claims. The 2025 regulation establishes formal algorithms for evaluating both registered and novel strain combinations.

4. Product Quality Standards: Labels must state the live probiotic count in colony-forming units (CFUs) and demonstrate that this count remains stable until the end of shelf life. Storage conditions that affect viability must also be declared.

The regulation also restricts the use of the word “probiotic” on product labels. Only products containing live microorganisms at proven doses with documented health benefits may carry this designation.

Brands cannot use it loosely as a marketing term. For foreign companies accustomed to more flexible regulatory environments, this is a significant change that affects both formulation and label design.

PerBPOM 17/2025 is a clear signal from BPOM: the era of loosely evidenced probiotic claims in Indonesia is over. Science-backed documentation is now the price of market entry.

Market Entry Strategy for Foreign Probiotic Brands

Entering the Indonesian market requires more than a good product. Foreign probiotic brands must navigate a layered set of legal, regulatory, and certification requirements, each of which needs to be in place before a single unit can be legally sold.

This section covers the four pillars of market entry: legal entity setup (PT PMA or License Holder), BPOM product registration, and halal certification.

Option 1: Establishing a PT PMA

Foreign companies cannot register a product with BPOM under their overseas legal identity. Indonesia requires the holder of a distribution permit (izin edar) to be a legally established Indonesian entity.

For most foreign investors, this means setting up a PT PMA — Perseroan Terbatas Penanaman Modal Asing — the Indonesian framework for a foreign-owned limited liability company.

A PT PMA gives the foreign investor direct ownership, operational control, and the legal standing required to hold BPOM registrations, import goods, sign commercial contracts, and employ local staff.

It is the most comprehensive legal vehicle for a serious long-term market presence.

Option 2: Using a License Holder

For smaller foreign operators or exporters not yet ready to incorporate, an alternative is to use a local Indonesian company as a ライセンス所有者.

Under this arrangement, a trusted local entity holds the BPOM registration on behalf of the foreign brand. This reduces setup cost and time significantly.

However, it requires careful due diligence on the local partner. Product Registration Indonesia offers a License Holder service that allows foreign brands to enter the market without establishing a full legal entity, providing a reliable and neutral holding structure.

BPOM Product Registration (Izin Edar)

Regardless of the legal entity path chosen — PT PMA or License Holder — every probiotic supplement sold in Indonesia must hold a BPOM distribution permit, known as izin edar.

The general registration sequence is as follows:

5. Product Classification: Confirm the product is correctly classified as a health supplement (suplemen kesehatan) under BPOM’s taxonomy.

6. Prepare the Dossier: Compile all required documentation under PerBPOM 17/2025 — strain data, safety data, efficacy data, label drafts in Bahasa Indonesia, and GMP/ISO manufacturing certificates.

7. Laboratory Testing: Submit samples to a BPOM-accredited laboratory covering microbiological safety, heavy metals, and probiotic viability (CFU count).

8. Submit via e-Registration Portal: Applications are submitted online through BPOM’s official electronic registration system.

9. Respond to BPOM Queries: Evaluators commonly raise additional questions (deficiency letters). Timely, complete responses are critical to keeping the review on track.

10. Receive the Distribution Permit: Upon approval, BPOM issues the product registration number (POM SD… for health supplements). This number must appear on all product packaging.

For products using established, already-registered probiotic strains with a complete dossier, the process typically takes six to nine months from submission to permit issuance. Products involving new strains requiring clinical trials can take twelve to twenty-four months or longer.

ハラール認証

Indonesia’s mandatory halal certification law — governed by Law No. 33 of 2014 and implemented through Government Regulation No. 39 of 2021 — requires that health supplement products sold in Indonesia be halal-certified.

The Halal Product Assurance Organising Agency (BPJPH) oversees this certification, replacing MUI as the primary certifying authority.

For probiotic supplements, halal certification carries particular complexity. The probiotic strains are derived from biological sources, which raises questions about the origin of culture media, fermentation substrates, and encapsulation materials.

Commonly used gelatin capsules, for instance, must be from halal-certified bovine or plant-based sources. Cross-contamination at the manufacturing facility with non-halal materials must also be addressed.

What the Halal Certification Process Involves

•   Submission of a halal application to BPJPH, with supporting documentation on ingredients, production processes, and supply chain.

•   Audit by a BPJPH-accredited Halal Inspection Body (LPH).

•   Review and issuance of the halal fatwa by the Indonesian Ulema Council (MUI), which feeds back into BPJPH’s certification decision.

•   Issuance of the Halal Certificate, valid for four years, after which it must be renewed.

•   Mandatory display of the halal logo on product packaging.

International halal certificates (such as those from Malaysia, the UAE, or Singapore) may be accepted in some circumstances under mutual recognition agreements, but this is not guaranteed for all certification bodies.

Foreign brands should verify equivalence before relying on existing overseas certifications.

Operational Compliance After Registration

Receiving a BPOM distribution permit (izin edar) is a milestone, not a finish line. Indonesia’s regulatory environment requires ongoing compliance across several dimensions.

•   Label Compliance: Any change to product labelling — including ingredient quantities, usage instructions, or health claims — requires a label variation submission to BPOM before implementation.

•   Good Distribution Practices (CDOB): Importers and distributors must maintain cold-chain integrity and warehousing standards consistent with probiotic viability requirements.

•   Post-Market Surveillance: BPOM conducts market monitoring and product testing. Products found non-compliant can face recall orders, permit suspension, or revocation.

•   Permit Renewal: BPOM distribution permits are typically valid for five years and must be renewed before expiry.

•   Pharmacovigilance Reporting: If adverse events are reported in connection with a registered supplement, the permit holder has notification obligations to BPOM.

•   Halal Certificate Renewal: The BPJPH halal certificate must be renewed every four years, and any formula change triggers a re-certification requirement.

Foreign companies operating without a dedicated in-country regulatory affairs team often struggle at this stage. Partnering with a local registration expert, or using a licensed local entity as permit holder, is a practical way to ensure ongoing compliance without building a full internal function from day one.

Common Mistakes Foreign Investors Make with BPOM Probiotic Registration

The pattern of avoidable mistakes is strikingly consistent across foreign supplement companies. Here are the most common pitfalls. 

1. Assuming Overseas Approvals Transfer Automatically

A product approved by the US FDA, TGA Australia, or the European Food Safety Authority carries zero automatic standing with BPOM. Indonesia conducts its own independent assessment. Overseas registration data can support an application, but it does not replace it.

2. Misclassifying the Product

Indonesia distinguishes between health supplements (suplemen kesehatan), traditional medicines (obat tradisional), and quasi-medicines (obat kuasi). Errors in classification at application stage delay the process significantly and sometimes require resubmission.

3. Submitting Incomplete Strain Documentation

Under PerBPOM 17/2025, the depth of strain documentation required is far greater than many foreign companies anticipate. Vague supplier Certificates of Analysis are insufficient. BPOM expects formal strain identification data, safety profiles, and where applicable, clinical efficacy documentation.

4. Ignoring Halal from the Start

Companies that finalise formulation, sourcing, and manufacturing before considering halal requirements often discover mid-process that a key ingredient or capsule material is non-compliant. Retrofitting halal compliance is expensive and time-consuming. Halal should be integrated from the formulation stage.

5. Underestimating the Timeline

The BPOM registration process for health supplements typically takes between six and twelve months from complete submission to permit issuance. For products requiring clinical trials, the timeline extends significantly. Foreign companies that plan a product launch around an optimistic three-month timeline consistently find themselves in difficulty.

6. Using Unreliable Local Partners

Indonesia’s regulatory system requires the permit holder to be an Indonesian entity. Foreign companies that rush into agreements with unvetted local distributors — who then hold their BPOM registration — can find themselves with no control over their own permits. Neutral, professional license-holding arrangements are the safer path.

How Product Registration Indonesia Supports Foreign Probiotic Brands

Navigating the intersection of BPOM science requirements, halal certification, PT PMA corporate law, and ongoing operational compliance is genuinely complex.

stage-main-2025.productregistrationindonesia.com/ (PRI) is a specialist regulatory consultancy focused exclusively on the Indonesian market. PRI offers end-to-end support across the full lifecycle of product registration and compliance.

PRI’s Core Services for Probiotic Supplement Brands

•   Food Supplements Registration: Full dossier preparation, BPOM portal submission, and query management under the latest BPOM regulations including PerBPOM 17/2025.

•   Halal Certification: End-to-end support for BPJPH certification, from ingredient review to audit preparation and certificate management.

•   License Holder Service: A neutral, professional local entity that holds BPOM permits on behalf of foreign brands, providing security and independence from commercial distributors.

•   Undername Export and Import Services: Allowing foreign companies to import products into Indonesia without establishing their own PT PMA.

•   Regulatory Consulting: Strategic advisory for product classification, claim compliance, label review, and regulatory change management.

PRI brings deep institutional knowledge of both the letter and the practice of Indonesian regulations — understanding not just what the rules say, but how BPOM evaluators apply them in practice.

For foreign brands facing the new PerBPOM 17/2025 framework, that practical expertise can be the difference between a smooth approval and months of costly back-and-forth.

Ready to Enter Indonesia’s Probiotic Market the Right Way?

Indonesia’s new regulatory landscape for probiotic supplements is rigorous. But for foreign brands willing to approach it strategically, it represents a powerful competitive differentiator.

The companies that invest in proper BPOM probiotic supplement registration processes, build genuine clinical evidence, align with halal requirements from the start, and work with experienced local regulatory partners will be the ones writing success stories in this market.

The complexity of PerBPOM 17/2025 — combined with halal certification obligations, PT PMA or license holder considerations, and ongoing compliance demands — is not something to navigate alone.

We combine deep expertise, robust systems, and established industry relationships to support foreign supplement brands; from initial market assessment to securing distribution approval and beyond.

Do not let regulatory complexity become the reason a strong product never reaches Indonesian consumers. Reach out to Product Registration Indonesia today for a free initial consultation and a clear roadmap tailored to your probiotic supplement.

よくある質問

1. What is PerBPOM 17/2025 and how does it differ from the previous regulation?

PerBPOM 17/2025 is BPOM Regulation Number 17 of 2025 on Guidelines for Assessment of Health Supplement Products Containing Probiotics, signed on 23 June 2025. It replaces PerBPOM 17/2021.

The key differences include mandatory clinical trial requirements for new or combined probiotic strains, stricter strain identification standards, clearer CFU labelling obligations, and a formal algorithmic framework for evaluating both registered and novel strains. The 2021 regulation provided general guidance; the 2025 version creates a structured, science-based evaluation system.

2. Can a foreign company register a probiotic supplement with BPOM without setting up a PT PMA?

Yes, in practice. A foreign brand can use a Licensed Local Entity (license holder) to hold the BPOM registration in Indonesia. This avoids the cost and complexity of PT PMA incorporation while still achieving legal market access.

However, it requires a trustworthy and professionally managed local partner. PRI’s License Holder service is specifically designed to provide this in a neutral, conflict-free arrangement.

3. Is halal certification mandatory for probiotic supplements sold in Indonesia?

Under Law No. 33 of 2014 and its implementing regulations, halal certification is mandatory for food and health supplement products sold in Indonesia. This includes probiotic supplements. Products without valid halal certification cannot legally be sold once the mandatory phase fully applies to their product category.

4. How long does the BPOM registration process take for a probiotic supplement?

For products using established, already-registered probiotic strains with a complete and well-prepared dossier, the process typically takes six to nine months from submission to permit issuance.

Products involving new strains that require clinical trials conducted in Indonesia can take twelve to twenty-four months or longer, depending on the scope of the trial and BPOM’s evaluation queue.

5. What labelling information is mandatory under PerBPOM 17/2025?

Labels must include the full scientific name of each probiotic strain (genus, species, and strain designation), the quantity of live organisms in colony-forming units (CFUs) at the time of consumption (not just at manufacture), required storage conditions that affect viability, and usage instructions based on clinical evidence.

BPOM Regulation No. 10 of 2024 on supplement labelling also requires the halal logo where applicable, the distribution permit number, and labelling in Bahasa Indonesia.

6. What happens if a product already on the Indonesian market does not comply with PerBPOM 17/2025?

BPOM has called on all business actors to immediately align their registration and product standards with the new regulation. Products currently in the market that were registered under the 2021 framework should be reviewed against the new requirements, particularly regarding labelling and documentation.

Non-compliance discovered through post-market surveillance can lead to product recall, permit suspension, or revocation. Proactive compliance review is strongly recommended.